This Week in PNAS

In a study slated to appear in the early, online edition of the Proceedings of the National Academy of Sciences this week, an Ohio State University-led team assessed the expression of hundreds of microRNAs in ovarian cancer tumors, looking for those with expression profiles that coincided with chemotherapy resistance. Through an array-based analysis of almost 700 microRNAs in tumor samples from 86 women with ovarian cancer, researchers tracked down a 23-miRNA signature for chemoresistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

This Week in PNAS

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.